Skip to main content Skip to section navigation Skip to footer
  • Basic Research
  • Biopharma Products
  • Services
  • Resources
  • Support
  • About Enzo
Login or Register
Quick Order
  • Support & Help

Enzo Biochem, Inc Corporate Home

  • Support & Help

Enzo Biochem, Inc Corporate Home

Login or Register
$0.00 0 products

Your Cart

No products in the cart.

Quick Order
  • Basic Research Products
  • Biopharma Products
  • Services
  • Resources
  • Support
  • About Enzo

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Company Profile
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote and Chart
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Press Releases
  • IR Calendar
  • Email Alerts
Jan 13, 2010 11:00 am EST
Enzo Biochem Reports That Its Clinical Labs Division Has Available Newly Authorized Swine Flu (H1N1) Test
Dec 10, 2009 4:10 pm EST
Enzo Biochem Reports Sharply Improved First Quarter Results
Dec 10, 2009 11:43 am EST
Enzo Biochem's Clinical Labs Division Signs Exclusive Marketing Agreement with Ikonisys for Proprietary Molecular-Based Cervical Cancer Test
Dec 7, 2009 1:56 pm EST
Enzo Biochem Schedules Teleconference to Discuss First Quarter 2010 Results for December 11, 2009, at 8:30 AM E.T.
Nov 25, 2009 6:19 pm EST
Enzo Biochem, Inc. Announces Departure of Its Secretary and Treasurer
Nov 18, 2009 7:09 am EST
Enzo Biochem's Clinical Lab Enters Exclusive Agreement with GeneNews to Market Blood Test for Colorectal Cancer
Nov 13, 2009 10:00 am EST
Enzo Biochem Executive to Discuss Oral Immune Regulation Platform at Windhover TA Partnerships 2009 Conference
Nov 11, 2009 3:23 pm EST
Enzo Biochem to Present at Lazard Capital Markets 6th Annual Healthcare Conference
Nov 4, 2009 8:53 am EST
Enzo Biochem Executive Says Oral Immune Regulation Platform Shows "Therapeutic Promise"
Nov 2, 2009 9:00 am EST
Enzo Biochem Reports on Favorable Clinical Trial of EGS21 for Treatment of Non-Alcoholic Steatohepatitis
  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 23
  • Page 24
  • Page 25
  • Page 26
  • Page 27
  • Page 28
  • Page 29
  • Page 30
  • Page 31
  • Page 32
  • …
  • Page 34
  • Next Pagearrow_forward
rss_feed News RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
  • account_treeSitemap
  • accessibilityAccessibility Statement
Enzo logo
  • Who We Serve
    • Academic Research
    • Biotech & Pharma
    • CROs
    • Diagnostic Manufacturers
  • Our Offering
    • Basic Research Products
    • Biopharma Products
  • Resources
    • Blogs
    • Scientific Literature
    • Application Notes
    • E-Books
    • Webinars
  • Support
    • Your Account
    • Online Support
    • FAQs
    • Programs & Offers
    • Customer Service
    • Technical Support
    • Clinical Lab Results
  • About Enzo
    • Investors
    • Scientists Enabling Scientists
    • Careers
    • Partnering with Us
  • Legal
    • Terms & Conditions
    • Disclaimer
    • Privacy Policy
    • Cookie Policy
    • Cookie Preferences
    • Safe Harbor Statement
    • Intellectual Property
    • Global HIPAA Notice
    • Modern Slavery and Human Trafficking Statement
Follow us: Facebook Instagram LinkedIn X/Twitter
Copyright © 2025 Enzo Biochem Inc.

Welcome to Enzo’s new website, Enzo.com

You’re in the right place!

Enzo’s new website has combined Enzo.com, Enzolifesciences.com, and Axxora.com all in one great site!